ACIP doesn’t have the regulatory authority to officially recommend a booster shot, but it presented data showing that a booster shot would help immunocompromised people fight off COVID-19.
Almost 3 percent of all U.S. adults are immunocompromised, including transplant recipients, some cancer survivors and people with HIV, according to the CDC. Vaccines often aren’t as effective in immunocompromised people, as they require their immune system to be stimulated in order to protect them against disease.
The presenters discussed four small studies involving transplant and dialysis patients who did not develop antibodies after receiving their first two COVID-19 vaccine doses. After a third dose, 33 percent to 50 percent of them developed antibodies to fight COVID-19.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
